Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.
Saved in:
| Title: | Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab. |
|---|---|
| Authors: | Wang Y; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., Bukkems LH; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., van Hasselt JGC; Leiden Academic of Drug research, Leiden, the Netherlands., Crombag MR; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Dumoulin D; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hendrikx JJMA; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands., Theelen W; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, the Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, the Netherlands., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., Becker A; Department of Pulmonology, Amsterdam University Medical Center, the Netherlands., Hiltermann J; Department of Pulmonology, University of Groningen, University Medical Center Groningen, the Netherlands., Hendriks LEL; Department of Pulmonary Diseases, GROW - Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands., van Geel RMJM; Department of Clinical Pharmacy & Toxicology, NUTRIM Research Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, the Netherlands., van Geffen WH; Department of Pulmonology, Radboudumc, Nijmegen, the Netherlands., van den Heuvel M; Department of Pulmonology, University Medical Center Utrecht, the Netherlands., Oude Munnink TH; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands., Smit EF; Department of Pulmonology, Leiden University Medical Center, the Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands. Electronic address: d.j.a.r.moes@lumc.nl., Ter Heine R; Department of Pharmacy, Pharmacology and Toxicology, Radboudumc, Nijmegen, the Netherlands. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 May 23; Vol. 243, pp. 116829. Date of Electronic Publication: 2026 May 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
